So far, (CBD) has monopolized media coverage of legal cannabinoids, giving the authorities a hard time: is it allowed? Is it forbidden? Can it be incorporated into food? In cosmetics. Each product category judges it differently, a complexity amplified by the regulatory differences between each European Union country, not to mention of course the United States or Canada.
But cannabigerol (CBG) is also one of the non-psychotropic cannabinoids . It is present in very small quantities in most THC varieties, and more so in industrial hemp varieties, which have so far been little restricted to maximize the presence of CBG, but its properties are beginning to attract the attention of health professionals and consumers.
CBG is the precursor of all cannabinoids. Initially present in its acidic form of CBGA, it is transformed into CBG under the action of time and heat, then decomposes into THC, CBD, CBC…
Like CBD, CBG is not psychotropic. There has been little research to date on the effects of CBG on humans, but several animal studies have identified the significant potential for medical use.
Animal studies have shown that CBG stimulates the receptors involved in pain and heat sensation and can also stimulate a2-adrenergic receptors in the brain and blood vessels, which play a role in regulating blood pressure. CBG also has certain anti-inflammatory properties.
However, these effects are also observed with CBD, which is produced by the plant in larger quantities, without specifying differences in effect with CBG at this time.
Two animal studies also examined specific diseases. They have shown that CBG can be beneficial in inflammatory bowel diseases (such as ulcerative colitis and Crohn’s disease) and Huntington’s disease (an incurable brain disease). In vitro studies have also shown that CBG has antibacterial properties and prevents colon cancer.
In addition, it could increase dopamine levels and support sleep and appetite regulation. CBG has also shown its effectiveness in the treatment of glaucoma, cancer, and methicillin-resistant Staphylococcus aureus.
More research will, of course, be needed to draw conclusive conclusions for humans. However, since the profile of this cannabinoid closely resembles CBD, with complementary properties, it could become more democratic following CBD. Some CBD oils also incorporate CBG at 1 :1 ratios.